Gu-ping Tang-Guping
Hangzhou, 310003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Redox-driven hybrid nanoenzyme dynamically activating ferroptosis and disulfidptosis for hepatocellular carcinoma theranostics.
Journal: Journal of colloid and interface science
Published: January 26, 2025
Hyperthermia-induced stellate cell deactivation to enhance dual chemo and pH-responsive photothermal therapy for pancreatic cancers.
Journal: Nanoscale
Published: October 07, 2022
Block copolymer [(L-GluA-5-BE)-b-(L-AspA-4-BE)]-based nanoflower capsules with thermosensitive morphology and pH-responsive drug release for cancer therapy.
Journal: Journal of materials chemistry. B
Published: September 24, 2020
Cyclodextrin-based host-guest complexes loaded with regorafenib for colorectal cancer treatment.
Journal: Nature communications
Published: December 20, 2019
Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complex.
Journal: Biomaterials science
Published: September 12, 2019
Reverting chemoresistance of targeted agents by a ultrasoluble dendritic nanocapsule.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 02, 2019
A PEGylated megamer-based microRNA delivery system activatable by stepwise microenvironment stimulation.
Journal: Chemical communications (Cambridge, England)
Published: July 19, 2019
Macrocyclic Compounds for Drug and Gene Delivery in Immune-Modulating Therapy.
Journal: International journal of molecular sciences
Published: April 02, 2019
Light-enhanced hypoxia-responsive nanoparticles for deep tumor penetration and combined chemo-photodynamic therapy.
Journal: Chemical communications (Cambridge, England)
Published: November 07, 2018
A Phytochemical-Based Copolymer Derived from Coriolus versicolor Polysaccharopeptides for Gene Delivery.
Journal: Molecules (Basel, Switzerland)
Published: July 11, 2018
Reactive oxygen species (ROS)-responsive nanomedicine for RNAi-based cancer therapy.
Journal: Nanoscale
Published: December 07, 2017
Last Updated: 09/26/2026